Magnetic nanoparticles: Applications in gene delivery and gene therapy
Source abstract
Abstract
Gene therapy is defined as the direct transfer of genetic material to tissues or cells for the treatment of inherited disorders and acquired diseases. For gene delivery, magnetic nanoparticles (MNPs) are typically combined with a delivery platform to encapsulate the gene, and promote cell uptake. Delivery technologies that have been used with MNPs contain polymeric, viral, as well as non-viral platforms. In this review, we focus on targeted gene delivery using MNPs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
,
Higher Academic Education Institute of Rabe Rashid, Tabriz, Iran
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
References (100+)
Show source-provided references
1. Abbasi E, Abolfazl A, Kouhi M, Milani M. 2014a. Graphene: Synthesis, Bio-Applications, and Properties. Artif Cells Nanomed Biotechnol. 1–7.
2. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
3. Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H. 2014c. Silver nanoparticles: synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 1–8.
4. Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H, et al. 2014d. Silver nanoparticles: Synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 1–8.
5. Afsaneh S, Reza HH, Mohammad AB, Shayan Z, Nosratolah Z, Abolfazl A. 2014. The association between serum KALRN levels with polymorphism gene KALRN (rs9289231) with risk of early-onset coronary artery disease (CAD). Molecular Biology Reports.
6. 10.1007/s11033-013-3014-410.1007/s11033-013-3014-4 ↗
7. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
8. Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012a.Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–526.
9. 10.1186/1556-276X-7-14410.1186/1556-276X-7-144 ↗
10. Akbarzadeh A, Samiei M, Davaran S. 2012c.Magnetic Nanoparticles: Preparation, Physical Properties and Applications in biomedicine. Nanoscale Res lett. 7:144–157.
11. 10.1186/1477-3155-10-4610.1186/1477-3155-10-46 ↗
12. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012e. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5:13–25.
13. 10.7314/APJCP.2014.15.1.4910.7314/APJCP.2014.15.1.49 ↗
14. Alizadeh E, Akbarzadeh A, Zarghami N, Eslaminejad BM, Hashemzadeh S, Nejati-Koshki K. 2014. Up-regulation of Liver enriched Transcription Factors (HNF4a and HNF6) and Liver Specific MicroRNA (miR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells. Chem Biol Drug Des. 85:600–608.
15. Alizadeh E, Zarghami N, Eslaminejad BM, Akbarzadeh A, Barzegar A, Mohammadi SA. 2014. The Effect of Dimethyl Sulfoxide (DMSO) on Hepatic Differentiation of Mesenchymal Stem Cells. Artif Cells Nanomed Biotechnol. 1–8.
16. Anganeh MT, Mirakabad FST, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014a. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4:134–145.
17. Anganeh TM, Mirakabad FST, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014b. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosciences. 4: 134–145.
18. 10.7314/APJCP.2014.15.20.893110.7314/APJCP.2014.15.20.8931 ↗
19. Badrzadeh F, Rahmati-Yamchi M, Badrzadeh K, Valizadeh A, Zarghami N, Farkhani SM, Akbarzadeh A. 2014b. Drug delivery and nanodetection in lung cancer. Artif Cells Nanomed Biotechnol. Early Online:1–17.
20. Barkhordari A, Rahmati YM, Fekri S, Pourhassan-Moghaddam M, Nejati KK, Davaran S, et al. 2014. Study of inhibitory effect of Helenalin on hTERT gene expression in breast cancer cell line by Real-time PCR. Bio infopublications. In Press 2014.
21. 10.1073/pnas.050492610210.1073/pnas.0504926102 ↗
22. 10.1074/jbc.M01087320010.1074/jbc.M010873200 ↗
23. 10.3109/0265204960902601310.3109/02652049609026013 ↗
24. Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2014. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 1–8.
25. 10.1016/S0065-2660(05)53001-310.1016/S0065-2660(05)53001-3 ↗
26. 10.7314/APJCP.2014.15.20.888310.7314/APJCP.2014.15.20.8883 ↗
27. Dadashzadeh K, Milani M, Rahmati M, Akbarzadeh A. 2014b.Real-Time PCR detection of 16S rRNA novel mutations associated with Helicobacter pylori tetracycline resistance in Iran. APJCP. 15: 8883–8886.
28. Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 1–13.
29. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2014b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 1–11.
30. 10.4236/jeas.2013.3401310.4236/jeas.2013.34013 ↗
31. 10.4236/anp.2014.3100310.4236/anp.2014.31003 ↗
32. Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Movassaghpour AA, Alipour M, Nejati-Koshki K, et al. 2014. Molecular Target Therapy of AKT and NF-kB Signaling Pathways and Multidrug Resistance by Specific Cell Penetrating Inhibitor Peptides in HL-60 Cells. APJCP. 15:4353.
33. 10.1097/MNH.0b013e32831c50a110.1097/MNH.0b013e32831c50a1 ↗
34. 10.1186/1556-276X-9-25210.1186/1556-276X-9-252 ↗
35. 10.1038/sj.gt.330272010.1038/sj.gt.3302720 ↗
36. 10.1186/1556-276X-9-39310.1186/1556-276X-9-393 ↗
37. Eatemadi A, Daraee H, Zarghami N, Melat YH, Akbarzadeh A, Hanifehpour Y. 2014b. Nanofiber; synthesis and biomedical applications Artif Cells Nanomed Biotechnol. 1–11.
38. Ebrahimi E, Abbasi E, Akbarzadeh A, Khandaghi AA, Davaran S. 2014a. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol. 1–8.
39. Ebrahimi E, Khandaghi AA, Valipour F, Babaie S, Asghari F, Motaali S, et al. 2014b. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers. Artifi Cells Nanomed Biotechnol. Early Online:1–9.
40. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts. 3:67–74.
41. 10.1109/LAWP.2010.204381010.1109/LAWP.2010.2043810 ↗
42. Fekri Aval S, Akbarzadeh A, Yamchi MR, Zarghami F, Nejati-Koshki K, Zarghami N. 2014. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol. Early Online:1–6.
43. 10.7314/APJCP.2014.15.17.711310.7314/APJCP.2014.15.17.7113 ↗
44. 10.7314/APJCP.2013.14.11.694910.7314/APJCP.2013.14.11.6949 ↗
45. 10.1021/cm020994n10.1021/cm020994n ↗
46. 10.1016/j.biomaterials.2009.10.01210.1016/j.biomaterials.2009.10.012 ↗
47. 10.1016/S0079-6123(03)46029-910.1016/S0079-6123(03)46029-9 ↗
48. Herizchi R, Abbasi E, Milani M, Akbarzadeh A. 2014. Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol. Early Online:1–7.
49. 10.1016/j.jconrel.2009.01.02410.1016/j.jconrel.2009.01.024 ↗
50. 10.1111/cbdd.1231810.1111/cbdd.12318 ↗
51. 10.1006/mthe.2001.026810.1006/mthe.2001.0268 ↗
52. 10.1002/jgm.57710.1002/jgm.577 ↗
53. Indira TK, Lakshmi PK. 2010. Magnetic nanoparticles - A review. Int J Pharm Sci Nanotechnol. 3:1035–1042.
54. 10.1007/s11033-014-3553-310.1007/s11033-014-3553-3 ↗
55. 10.7150/thno.691410.7150/thno.6914 ↗
56. Kafshdooz T, Kafshdooz L, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Applications of nanoparticle systems in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol. Early Online:1–7.
57. 10.3390/ijms1206370510.3390/ijms12063705 ↗
58. Kordi S, Zarghami N, Rahmati YM, Ghasemali S, Tozihi M, Nejati-Koshki K, Akbarzadeh A. 2014. The Comparison of inhibitory effect of nanocapsolated Helenalin and free Helenalin on Telomerase gene expression in breast cancer cell line by Real-time PCR. Artif Cells Nanomed Biotechnol. Early Online:1–17.
59. 10.1039/b307062j10.1039/b307062j ↗
60. 10.1186/1556-276X-9-13110.1186/1556-276X-9-131 ↗
61. Lee J-M, Yoon T-J, Cho Y-S. 2013. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int. 2013:782041
62. 10.18632/oncotarget.49010.18632/oncotarget.490 ↗
63. 10.1016/j.addr.2009.03.01410.1016/j.addr.2009.03.014 ↗
64. 10.1006/mthe.2000.017410.1006/mthe.2000.0174 ↗
65. 10.1006/mthe.2001.063610.1006/mthe.2001.0636 ↗
66. 10.1038/nrd196010.1038/nrd1960 ↗
67. Mayrhofer P, Schleef M, Jechlinger W. 2009. Use of minicircle plasmids for gene therapy, in Gene Therapy of Cancer. Springer, pp. 87–104.
68. 10.2147/ijn.s160810.2147/ijn.s1608 ↗
69. 10.7314/APJCP.2014.15.20.869310.7314/APJCP.2014.15.20.8693 ↗
70. 10.7314/APJCP.2013.14.11.692510.7314/APJCP.2013.14.11.6925 ↗
71. 10.1155/2012/29121910.1155/2012/291219 ↗
72. 10.1016/j.bbrc.2005.06.20410.1016/j.bbrc.2005.06.204 ↗
73. 10.1038/nnano.2009.20210.1038/nnano.2009.202 ↗
74. Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2014. Bimetallic nanoparticles: Preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 1–5.
75. 10.7314/APJCP.2013.14.11.659510.7314/APJCP.2013.14.11.6595 ↗
76. Nejati-Koshki K, Mesgari M, Ebrahimi E, Abhari A, Aval FS, Khandaghi AA, Akbarzadeh A. 2014. Synthesis and In-vitro study of Cisplatin-loaded Fe3O4 Nanoparticles Modified with PLGA-PEG6000 Copolymers in Treatment of Lung Cancer. J Microencapsulation. 1–9.
77. 10.1016/j.jmmm.2005.01.06410.1016/j.jmmm.2005.01.064 ↗
78. 10.1038/sj.gt.330192310.1038/sj.gt.3301923 ↗
79. 10.3390/ijms1401162910.3390/ijms14011629 ↗
80. 10.1038/nrd177510.1038/nrd1775 ↗
81. 10.1088/0022-3727/36/13/20110.1088/0022-3727/36/13/201 ↗
82. 10.1016/j.addr.2006.03.00710.1016/j.addr.2006.03.007 ↗
83. 10.1016/j.jconrel.2010.03.02510.1016/j.jconrel.2010.03.025 ↗
84. 10.1186/1556-276X-8-48510.1186/1556-276X-8-485 ↗
85. Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, de la Guardia M, Nejati-Koshki K. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Digital Library. 9:345–350.
86. 10.1016/S0169-409X(00)00133-210.1016/S0169-409X(00)00133-2 ↗
87. 10.2478/v10019-011-0001-z10.2478/v10019-011-0001-z ↗
88. 10.1038/nmat164510.1038/nmat1645 ↗
89. Rahimzadeh A, Tabatabaei Mirakabad FS, Movassaghpour A, Shamsasenjan K, Kariminekoo S, Talebi M, et al. 2014. Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system. Artifi Cells Nanomed Biotechnol. Early Online:1–12.
90. 10.1016/j.cjca.2011.02.00510.1016/j.cjca.2011.02.005 ↗
91. 10.4236/soft.2013.2300410.4236/soft.2013.23004 ↗
92. 10.1016/S0163-7258(98)00020-510.1016/S0163-7258(98)00020-5 ↗
93. 10.7314/APJCP.2014.15.2.51710.7314/APJCP.2014.15.2.517 ↗
94. 10.1038/sj.gt.330162410.1038/sj.gt.3301624 ↗
95. 10.3390/ijms1201001210.3390/ijms12010012 ↗
96. 10.2174/15665231280009961610.2174/156652312800099616 ↗
97. 10.1158/1535-7163.MCT-06-014110.1158/1535-7163.MCT-06-0141 ↗
98. Sohrabi N, Valizadeh A, Farkhani SM, Akbarzadeh A. 2014. Basics of DNA biosensors and cancer diagnosis. Artif Cells Nanomed Biotechnol. Early Online:1–10.
99. Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, et al. 2014. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 1–8.
100. 10.1038/nrg106610.1038/nrg1066 ↗